[Advantages of different dosages of active metabolites in the follow-up of azathioprine treatment for Crohn disease].
Authors:
- B CagnardBCB Cagnard
- D Tosoni-VerlingueDTD Tosoni-Verlingue
- O TributOTO Tribut
- C MoizardCMC Moizard
- L Bridoux-HennoLBL Bridoux-Henno
- N DelaperriereNDN Delaperriere
- D Bentue-FerrerDBD Bentue-Ferrer
- A DabadieADA Dabadie
- 1 October 2006
- journal article
- p. S67-8